Compare Aventis Pharma with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs PFIZER - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA PFIZER SANOFI INDIA/
PFIZER
 
P/E (TTM) x 34.5 33.3 103.7% View Chart
P/BV x 6.1 5.6 108.3% View Chart
Dividend Yield % 1.4 0.6 236.0%  

Financials

 SANOFI INDIA   PFIZER
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
PFIZER
Mar-18
SANOFI INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs6,8402,365 289.2%   
Low Rs4,6301,625 284.9%   
Sales per share (Unadj.) Rs1,203.1430.3 279.6%  
Earnings per share (Unadj.) Rs165.378.7 210.0%  
Cash flow per share (Unadj.) Rs209.993.2 225.2%  
Dividends per share (Unadj.) Rs84.0020.00 420.0%  
Dividend yield (eoy) %1.51.0 146.1%  
Book value per share (Unadj.) Rs963.6586.5 164.3%  
Shares outstanding (eoy) m23.0345.75 50.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.84.6 102.8%   
Avg P/E ratio x34.725.3 136.9%  
P/CF ratio (eoy) x27.321.4 127.6%  
Price / Book Value ratio x6.03.4 175.0%  
Dividend payout %50.825.4 200.0%   
Avg Mkt Cap Rs m132,07891,271 144.7%   
No. of employees `0003.32.6 125.5%   
Total wages/salary Rs m4,0683,143 129.4%   
Avg. sales/employee Rs Th8,393.87,484.8 112.1%   
Avg. wages/employee Rs Th1,232.41,195.0 103.1%   
Avg. net profit/employee Rs Th1,153.01,369.1 84.2%   
INCOME DATA
Net Sales Rs m27,70819,685 140.8%  
Other income Rs m8971,143 78.5%   
Total revenues Rs m28,60520,828 137.3%   
Gross profit Rs m6,2355,003 124.6%  
Depreciation Rs m1,027663 155.0%   
Interest Rs m74 166.7%   
Profit before tax Rs m6,0985,479 111.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2921,878 122.0%   
Profit after tax Rs m3,8063,601 105.7%  
Gross profit margin %22.525.4 88.5%  
Effective tax rate %37.634.3 109.6%   
Net profit margin %13.718.3 75.1%  
BALANCE SHEET DATA
Current assets Rs m15,92224,167 65.9%   
Current liabilities Rs m6,2359,544 65.3%   
Net working cap to sales %35.074.3 47.1%  
Current ratio x2.62.5 100.9%  
Inventory Days Days6455 115.5%  
Debtors Days Days2129 72.7%  
Net fixed assets Rs m7,5399,514 79.2%   
Share capital Rs m230458 50.3%   
"Free" reserves Rs m21,96226,375 83.3%   
Net worth Rs m22,19226,832 82.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m29,83936,900 80.9%  
Interest coverage x872.11,305.5 66.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.5 174.1%   
Return on assets %12.89.8 130.8%  
Return on equity %17.213.4 127.8%  
Return on capital %27.520.4 134.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58722 33,870.5%   
Fx outflow Rs m7,1451,489 479.9%   
Net fx Rs m442-1,466 -30.1%   
CASH FLOW
From Operations Rs m3,7393,318 112.7%  
From Investments Rs m-731-2,383 30.7%  
From Financial Activity Rs m-1,972-1,104 178.7%  
Net Cashflow Rs m1,036-169 -614.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 63.9 94.5%  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 4.9 298.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 23.7 44.3%  
Shareholders   15,184 85,207 17.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALEMBIC LTD  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  SUN PHARMA  

Compare SANOFI INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Sep 17, 2019 02:01 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS